Home » Lifestyle » Teenagers are latest participants in COVID-19 vaccine trials; safety concerns arise
Teenagers are latest participants in COVID-19 vaccine trials; safety concerns arise
AstraZeneca announces coronavirus vaccine up to 90% effective
FOX Business Network’s Blake Burman has the latest on AstraZeneca’s COVID-19 vaccine trial.
COVID-19 vaccine trials have shown promising results on adults thus far, but testing on children is just getting started.
Continue Reading Below
Clinical testing on children is the next major step among top candidates like Pfizer and Moderna, which have proven to meet the safety and immune response thresholds. After the Pfizer vaccine appeared to be nearly 95% effective in adults, the Cincinnati Children’s Hospital became one of the few sites to begin testing on adolescents.
Stocks in this Article
'GAME-CHANGER' CORONAVIRUS VACCINE COULD BE SOON ON THE WAY
Since April, the clinic has been one of five Pfizer pediatric testing sites working on COVID-19 vaccine trials on teenagers. A month into the clinical trial has already produced favorable results, signaling a nod to expand to even younger age groups.
“What we've seen so far is that safety has been very similar to the adults,” Dr. Robert Frenck told FOX Business. “We are seeing that some people are having aches and pains but nothing has been serious or caused a child to miss a day of school. We are very excited about that, and it really gives us heart that we will be able to move down further in age and actually may even need to go down as young as infants eventually to try to really stop this whole outbreak.”